NCT00694603 Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy Status TERMINATED Phase PHASE2
NCT00694577 Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast Cancer Status COMPLETED Phase NA
NCT00686855 Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease Status COMPLETED Phase PHASE2
NCT00681694 Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer Status UNKNOWN Phase N/A
NCT00680706 Thiamine and Acute Decompensated Heart Failure: Pilot Study Status COMPLETED Phase PHASE2
NCT00680407 Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis Status COMPLETED Phase PHASE2
NCT00680342 Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment Status COMPLETED Phase PHASE2
NCT00676585 Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest Status COMPLETED Phase PHASE1/PHASE2
NCT00673127 Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00670982 Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00658697 Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer Status COMPLETED Phase PHASE2
NCT00636909 Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders Status COMPLETED Phase PHASE2
NCT00631072 In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer Status COMPLETED Phase PHASE1
NCT00630344 RAD001 and Bicalutamide for Androgen Independent Prostate Cancer Status COMPLETED Phase PHASE2
NCT00626860 The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT00625755 A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma Status COMPLETED Phase PHASE1/PHASE2